Hello, everyone, and nice to see you again. We hope the weekend was refreshing and invigorating. Now, though, deadlines and meetings are looming once more. This was predictable, of course, so time to reach for a cup of stimulation to jumpstart the neurons, for better or worse. Please join us. We prefer not to drink alone this morning. Meanwhile, here are some tidbits to get you started, since there is much to do. Hope your day goes well and drop us a line if you run across something unusual or simply fascinating...
CVS Pays $650K For Dispending Incorrect Pills (NJ Star-Ledger)
Royalty Pharma Offers $6.5 Billion For Elan (Bloomberg News)
J&J Recalls Knee Replacement Device (Dow Jones)
FDA Approves Roche Drug For Late-Stage Breast Cancer (Reuters)
Allergan CEO Gets 51 Percent Pay Hike (Bloomberg News)
Novartis Shareholders Accept Pay System Despite Opposition (Reuters)
Merck Pays $8M To Settle Vioxx Lawsuit Filed By Pennsyvlania (Times-Herald)
QualiCaps To Create 123 Jobs In North Carolina (WGHP)
Merck KGgA Brain Tumor Drug Fails Clinical Trial (Reuters)
EMA Recommends Sanofi Six-In-One Pediatric Vaccine (Pharma Times)
South African API Plant Hits Delays (Financial Mail)
EDITOR'S NOTE: Please check this post for additional items during the day
sunshine pic thx to benimoto on flickr
1 Comment
I'm sure my mother will love to hear about this, after the last ten years she has been suffering from this product! Total Garbage! And the orthopedic surgeon who put in this garbage got his Fellowship from her case. Talk about adding insult to injury!